For COVID Drugs, Months of Frantic Development Lead to Few Outright Successes
There have been mixed results as researchers try to stop a disease they are still trying to understand -- Read more on ScientificAmerican.com
There have been mixed results as researchers try to stop a disease they are still trying to understand -- Read more on ScientificAmerican.com
There have been mixed results as researchers try to stop a disease they are still trying to understand -- Read more on ScientificAmerican.com
Bedside imaging holds vast potential as a diagnostic tool, especially during the pandemic -- Read more on ScientificAmerican.com
The data are preliminary, however, and it is not yet clear whether the vaccine protects against severe disease -- Read more on ScientificAmerican.com
Replacing humans with digital simulations could make clinical trials faster and safer -- Read more on ScientificAmerican.com
Replacing humans with digital simulations could make clinical trials faster and safer -- Read more on ScientificAmerican.com
Fewer trips to medical labs make care more accessible -- Read more on ScientificAmerican.com
Genetic engineering could allow for speedy production as well -- Read more on ScientificAmerican.com
Scientific American's senior medicine editor, Josh Fischman, talks about issues in medicine and public health that will be affected by this election. -- Read more on ScientificAmerican.com
Scientific American's senior medicine editor, Josh Fischman, talks about issues in medicine and public health that will be affected by this election. -- Read more on ScientificAmerican.com
Hospital workers who got vaccinated were significantly less likely to develop COVID than those who did not -- Read more on ScientificAmerican.com
Hospital workers who got vaccinated were significantly less likely to develop COVID than those who did not -- Read more on ScientificAmerican.com
Voters must decide whether to keep financing the second largest funder of stem cell science in the world -- Read more on ScientificAmerican.com
Voters must decide whether to keep financing the second largest funder of stem cell science in the world -- Read more on ScientificAmerican.com
It highlights one of the biggest problems in American health care -- Read more on ScientificAmerican.com
It highlights one of the biggest problems in American health care -- Read more on ScientificAmerican.com